netscientific
  • ABOUT US
  • TEAM
    • CAREERS
  • PORTFOLIO
  • INVESTORS
    • RNS & RNS REACH
    • FINANCIAL RESULTS
    • CORPORATE GOVERNANCE
  • NEWS
    • RESEARCH REPORTS
  • 2022 AGM NOTICE
  • CONTACT US
netscientific
netscientific
  • ABOUT US
  • TEAM
    • CAREERS
  • PORTFOLIO
  • INVESTORS
    • RNS & RNS REACH
    • FINANCIAL RESULTS
    • CORPORATE GOVERNANCE
  • NEWS
    • RESEARCH REPORTS
  • 2022 AGM NOTICE
  • CONTACT US

Board Change

Jan 15, 2020
-
News, RNS Announcements

NetScientific plc

(“NetScientific” or the “Company”)

Board Change

Resignation of Ian Postlethwaite as CEO, CFO and Company Secretary

London, UK – 15 January 2020:  NetScientific plc (AIM: NSCI), the transatlantic healthcare IP commercialisation Group, today announces that Ian Postlethwaite yesterday served six months’ notice to step down as CEO, CFO and Company Secretary. Ian’s departure date is scheduled for July 14th 2020 in accordance with his service agreement, and to ensure an orderly transition. Ian is leaving NetScientific after four years to pursue other career opportunities.

The Board is continuing with its strategy review to determine how best to optimise returns to shareholders and decide on the required management arrangements. The Board anticipates announcing the findings of that review in conjunction with the Company’s results for the year ended 31 December 2019.

The Board intends to commence a process for future appointments following the conclusion of that review.

 

Sir Richard Sykes, Chairman of the NetScientific, said: “Ian’s support has been valuable to NetScientific.  He has provided a safe pair of hands during this challenging time as we continue to make the most of our reduced central costs and maximise the potential in our remaining portfolio companies to deliver value to our shareholders.  The Board would like to put on record its gratitude to Ian for his contribution in the transitioning of NetScientific since he took over as CEO last year and previously as CFO, and we wish him every success in his future interests.”

Commenting on his resignation, Ian Postlethwaite, added: “I have thoroughly enjoyed working with the team at NetScientific and truly believe that our portfolio companies hold great promise.  Following last year’s changes, I have worked to transition the Company to a low cost operating model and have supported the development of its three key assets: with Glycotest Inc. concluding its Series A financing round with Shanghai Fosun Pharmaceutical Co. Ltd, PDS Biotechnology Corporation completing its all share merger with Edge Therapeutics, and ProAxsis forecasting to reach cash break-even this year.  ”

 

For more information, please contact:

 

NetScientific Tel: +44 (0)20 3514 1800
 
WH Ireland Limited (NOMAD, Financial Adviser and Broker)

Chris Fielding / Darshan Patel

Tel: +44 (0)20 7220 1666

 

About NetScientific

NetScientific PLC is a transatlantic healthcare IP commercialisation Group focused on technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people.

 

For more information, please visit the website at www.NetScientific.net

Share on FacebookShare on TwitterShare on Linkedin
← PREVIOUS POST
PDS Biotechnology proposed offering
NEXT POST →
Holding(s) in Company

 

NetScientific plc

Level 39,
One Canada Square,
London, E14 5AB

Tel: +44 20 3514 1800
www.netscientific.net
info@netscientific.net

  • RNS & RNS Reach
  • Financial Results
  • Financial Calendar
  • Corporate Governance
  • News
  • Historic Material
Copyright
Terms of Use
Board Change - NetScientific
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT